Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

Free Abstracts

  Alzheimer's Disease

  Free Subscription


19.02.2018

1 Alzheimers Dement
1 BMC Geriatr
1 Curr Alzheimer Res
18 J Alzheimers Dis
1 J Am Geriatr Soc
1 J Neuropsychol
1 Nat Rev Neurol
1 Nervenarzt
4 Neurobiol Aging
3 Neurobiol Dis
3 Neurology
1 Neuroreport
2 Neuroscience
1 PLoS One
2 Proc Natl Acad Sci U S A


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Alzheimers Dement

  1. JIA J, Wei C, Chen S, Li F, et al
    The cost of Alzheimer's disease in China and re-estimation of costs worldwide.
    Alzheimers Dement. 2018 Jan 11. pii: S1552-5260(17)33877.
    PubMed     Text format     Abstract available


    BMC Geriatr

  2. CHRISTENSEN IT, Larsson EM, Holm IE, Nielsen OBF, et al
    Olfactory testing in consecutive patients referred with suspected dementia.
    BMC Geriatr. 2017;17:129.
    PubMed     Text format     Abstract available


    Curr Alzheimer Res

  3. MARTINEZ-TORTEYA A, Gomez-Rueda H, Trevino V, Farber J, et al
    Identification and Temporal Characterization of Features Associated with the Conversion from Mild Cognitive Impairment to Alzheimer's Disease.
    Curr Alzheimer Res. 2018 Feb 1. pii: CAR-EPUB-88334.
    PubMed     Text format     Abstract available


    J Alzheimers Dis

  4. SCHWEDA M, Kogel A, Bartels C, Wiltfang J, et al
    Prediction and Early Detection of Alzheimer's Dementia: Professional Disclosure Practices and Ethical Attitudes.
    J Alzheimers Dis. 2018;62:145-155.
    PubMed     Text format     Abstract available

  5. IHARA M, Washida K
    Linking Atrial Fibrillation with Alzheimer's Disease: Epidemiological, Pathological, and Mechanistic Evidence.
    J Alzheimers Dis. 2018;62:61-72.
    PubMed     Text format     Abstract available

  6. WEZYK M, Szybinska A, Wojsiat J, Szczerba M, et al
    Overactive BRCA1 Affects Presenilin 1 in Induced Pluripotent Stem Cell-Derived Neurons in Alzheimer's Disease.
    J Alzheimers Dis. 2018;62:175-202.
    PubMed     Text format     Abstract available

  7. XU L, Zhang W, Liu X, Zhang C, et al
    Circulatory Levels of Toxic Metals (Aluminum, Cadmium, Mercury, Lead) in Patients with Alzheimer's Disease: A Quantitative Meta-Analysis and Systematic Review.
    J Alzheimers Dis. 2018;62:361-372.
    PubMed     Text format     Abstract available

  8. JESKO H, Lukiw WJ, Wilkaniec A, Cieslik M, et al
    Altered Expression of Urea Cycle Enzymes in Amyloid-beta Protein Precursor Overexpressing PC12 Cells and in Sporadic Alzheimer's Disease Brain.
    J Alzheimers Dis. 2018;62:279-291.
    PubMed     Text format     Abstract available

  9. CORVOL A, Netter A, Campeon A, Somme D, et al
    Implementation of an Occupational Therapy Program for Alzheimer's Disease Patients in France: Patients' and Caregivers' Perspectives.
    J Alzheimers Dis. 2018;62:157-164.
    PubMed     Text format     Abstract available

  10. MULLAN K, Cardwell CR, McGuinness B, Woodside JV, et al
    Plasma Antioxidant Status in Patients with Alzheimer's Disease and Cognitively Intact Elderly: A Meta-Analysis of Case-Control Studies.
    J Alzheimers Dis. 2018;62:305-317.
    PubMed     Text format     Abstract available

  11. BABILONI C, Del Percio C, Lizio R, Noce G, et al
    Abnormalities of Resting State Cortical EEG Rhythms in Subjects with Mild Cognitive Impairment Due to Alzheimer's and Lewy Body Diseases.
    J Alzheimers Dis. 2018;62:247-268.
    PubMed     Text format     Abstract available

  12. BETTCHER BM, Johnson SC, Fitch R, Casaletto KB, et al
    Cerebrospinal Fluid and Plasma Levels of Inflammation Differentially Relate to CNS Markers of Alzheimer's Disease Pathology and Neuronal Damage.
    J Alzheimers Dis. 2018;62:385-397.
    PubMed     Text format     Abstract available

  13. HAAPALINNA F, Kokki M, Jaaskelainen O, Hallikainen M, et al
    Subtle Cognitive Impairment and Alzheimer's Disease-Type Pathological Changes in Cerebrospinal Fluid are Common Among Neurologically Healthy Subjects.
    J Alzheimers Dis. 2018;62:165-174.
    PubMed     Text format     Abstract available

  14. WATREMEZ W, Jackson J, Almari B, McLean SL, et al
    Stabilized Low-n Amyloid-beta Oligomers Induce Robust Novel Object Recognition Deficits Associated with Inflammatory, Synaptic, and GABAergic Dysfunction in the Rat.
    J Alzheimers Dis. 2018;62:213-226.
    PubMed     Text format     Abstract available

  15. ZHOU F, Chen S
    Effects of Gender and Other Confounding Factors on Leptin Concentrations in Alzheimer's Disease: Evidence from the Combined Analysis of 27 Case-Control Studies.
    J Alzheimers Dis. 2018;62:477-486.
    PubMed     Text format     Abstract available

  16. REALE M, D'Angelo C, Costantini E, Di Nicola M, et al
    Expression Profiling of Cytokine, Cholinergic Markers, and Amyloid-beta Deposition in the APPSWE/PS1dE9 Mouse Model of Alzheimer's Disease Pathology.
    J Alzheimers Dis. 2018;62:467-476.
    PubMed     Text format     Abstract available

  17. MAHADY L, Nadeem M, Malek-Ahmadi M, Chen K, et al
    Frontal Cortex Epigenetic Dysregulation During the Progression of Alzheimer's Disease.
    J Alzheimers Dis. 2018;62:115-131.
    PubMed     Text format     Abstract available

  18. MALPAS CB, Saling MM, Velakoulis D, Desmond P, et al
    Cerebrospinal Fluid Biomarkers are Differentially Related to Structural and Functional Changes in Dementia of the Alzheimer's Type.
    J Alzheimers Dis. 2018;62:417-427.
    PubMed     Text format     Abstract available

  19. FREEZE WM, Jacobs HI, Gronenschild EH, Jansen JF, et al
    White Matter Hyperintensities Potentiate Hippocampal Volume Reduction in Non-Demented Older Individuals with Abnormal Amyloid-beta.
    J Alzheimers Dis. 2017;55:333-342.
    PubMed     Text format     Abstract available

  20. RUSSELL CL, Mitra V, Hansson K, Blennow K, et al
    Comprehensive Quantitative Profiling of Tau and Phosphorylated Tau Peptides in Cerebrospinal Fluid by Mass Spectrometry Provides New Biomarker Candidates.
    J Alzheimers Dis. 2017;55:303-313.
    PubMed     Text format     Abstract available

  21. VOGELGSANG J, Wedekind D, Bouter C, Klafki HW, et al
    Reproducibility of Alzheimer's Disease Cerebrospinal Fluid-Biomarker Measurements under Clinical Routine Conditions.
    J Alzheimers Dis. 2018;62:203-212.
    PubMed     Text format     Abstract available


    J Am Geriatr Soc

  22. FAES K, Cohen J, Annemans L
    Resource Use During the Last 6 Months of Life of Individuals Dying with and of Alzheimer's Disease.
    J Am Geriatr Soc. 2018 Feb 15. doi: 10.1111/jgs.15287.
    PubMed     Text format     Abstract available


    J Neuropsychol

  23. WONG S, Irish M, Savage G, Hodges JR, et al
    Strategic value-directed learning and memory in Alzheimer's disease and behavioural-variant frontotemporal dementia.
    J Neuropsychol. 2018 Feb 12. doi: 10.1111/jnp.12152.
    PubMed     Text format     Abstract available


    Nat Rev Neurol

  24. FYFE I
    Alzheimer disease: APOE epsilon4 affects cognitive decline but does not block benefits of healthy lifestyle.
    Nat Rev Neurol. 2018 Feb 9. pii: nrneurol.2018.16. doi: 10.1038/nrneurol.2018.
    PubMed     Text format    


    Nervenarzt

  25. FLIESSBACH K, Schneider A
    [Biomarker-based diagnostics of Alzheimer's disease : Concept of suspected non-Alzheimer pathology].
    Nervenarzt. 2018 Feb 8. pii: 10.1007/s00115-018-0488.
    PubMed     Text format     Abstract available


    Neurobiol Aging

  26. TOUSSAY X, Morel JL, Biendon N, Rotureau L, et al
    Presenilin 1 mutation decreases both calcium and contractile responses in cerebral arteries.
    Neurobiol Aging. 2017;58:201-212.
    PubMed     Text format     Abstract available

  27. MORETTI DV, Pievani M, Pini L, Guerra UP, et al
    Cerebral PET glucose hypometabolism in subjects with mild cognitive impairment and higher EEG high-alpha/low-alpha frequency power ratio.
    Neurobiol Aging. 2017;58:213-224.
    PubMed     Text format     Abstract available

  28. TANNINEN SE, Nouriziabari B, Morrissey MD, Bakir R, et al
    Entorhinal tau pathology disrupts hippocampal-prefrontal oscillatory coupling during associative learning.
    Neurobiol Aging. 2017;58:151-162.
    PubMed     Text format     Abstract available

  29. HARTLEY SL, Handen BL, Devenny D, Mihaila I, et al
    Cognitive decline and brain amyloid-beta accumulation across 3 years in adults with Down syndrome.
    Neurobiol Aging. 2017;58:68-76.
    PubMed     Text format     Abstract available


    Neurobiol Dis

  30. ZUO Z, Qi F, Yang J, Wang X, et al
    Immunization with Bacillus Calmette-Guerin (BCG) alleviates neuroinflammation and cognitive deficits in APP/PS1 mice via the recruitment of inflammation-resolving monocytes to the brain.
    Neurobiol Dis. 2017;101:27-39.
    PubMed     Text format     Abstract available

  31. SALAS IH, Weerasekera A, Ahmed T, Callaerts-Vegh Z, et al
    High fat diet treatment impairs hippocampal long-term potentiation without alterations of the core neuropathological features of Alzheimer disease.
    Neurobiol Dis. 2018 Feb 7. pii: S0969-9961(18)30033.
    PubMed     Text format     Abstract available

  32. ANDRE W, Nondier I, Valensi M, Guillonneau F, et al
    Identification of brain substrates of transglutaminase by functional proteomics supports its role in neurodegenerative diseases.
    Neurobiol Dis. 2017;101:40-58.
    PubMed     Text format     Abstract available


    Neurology

  33. BOTHA H, Mantyh WG, Graff-Radford J, Machulda MM, et al
    Tau-negative amnestic dementia masquerading as Alzheimer disease dementia.
    Neurology. 2018 Feb 7. pii: WNL.0000000000005124.
    PubMed     Text format     Abstract available

  34. MENDES A, Bertrand A, Lamari F, Colliot O, et al
    Cerebral microbleeds and CSF Alzheimer biomarkers in primary progressive aphasias.
    Neurology. 2018 Feb 14. pii: WNL.0000000000005165.
    PubMed     Text format     Abstract available

  35. KNOPMAN DS
    Sifting through a failed Alzheimer trial: What biomarkers tell us about what happened.
    Neurology. 2018 Feb 2. pii: WNL.0000000000005073.
    PubMed     Text format    


    Neuroreport

  36. OH M, Seo M, Oh SY, Kim H, et al
    Clinical significance of visually equivocal amyloid PET findings from the Alzheimer's Disease Neuroimaging Initiative cohort.
    Neuroreport. 2018 Feb 12. doi: 10.1097/WNR.0000000000000986.
    PubMed     Text format     Abstract available


    Neuroscience

  37. MURRAY HC, Swanson MEV, Dieriks BV, Turner C, et al
    Neurochemical Characterization of PSA-NCAM(+) Cells in the Human Brain and Phenotypic Quantification in Alzheimer's Disease Entorhinal Cortex.
    Neuroscience. 2018;372:289-303.
    PubMed     Text format     Abstract available

  38. SIMON E, Obst J, Gomez-Nicola D
    The evolving dialogue of microglia and neurons in Alzheimer's disease: microglia as necessary transducers of pathology.
    Neuroscience. 2018 Feb 7. pii: S0306-4522(18)30089.
    PubMed     Text format     Abstract available


    PLoS One

  39. MOSCONI L, Berti V, Quinn C, McHugh P, et al
    Correction: Perimenopause and emergence of an Alzheimer's bioenergetic phenotype in brain and periphery.
    PLoS One. 2018;13:e0193314.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  40. ZHOU X, Chen Y, Mok KY, Zhao Q, et al
    Identification of genetic risk factors in the Chinese population implicates a role of immune system in Alzheimer's disease pathogenesis.
    Proc Natl Acad Sci U S A. 2018 Feb 5. pii: 1715554115.
    PubMed     Text format     Abstract available

  41. HOU Y, Lautrup S, Cordonnier S, Wang Y, et al
    NAD(+) supplementation normalizes key Alzheimer's features and DNA damage responses in a new AD mouse model with introduced DNA repair deficiency.
    Proc Natl Acad Sci U S A. 2018 Feb 5. pii: 1718819115.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: